1. Home
  2. Analysis
  3. Colistimethate
  4. Oramorph-sr

Colistimethate and Oramorph sr drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported only by a few people who take Colistimethate and Oramorph sr together.

The phase IV clinical study analyzes what interactions people who take Colistimethate and Oramorph sr have. It is created by eHealthMe based on reports of 2 people who take the same drugs from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On May, 26, 2023

2 people who take Colistimethate and Oramorph sr together, and have interactions are studied.

What is Colistimethate?

Colistimethate has active ingredients of colistimethate sodium. eHealthMe is studying from 1,185 Colistimethate users for its effectiveness, alternative drugs and more.

What is Oramorph sr?

Oramorph sr has active ingredients of morphine sulfate. It is often used in pain. eHealthMe is studying from 2,627 Oramorph sr users for its effectiveness, alternative drugs and more.

Number of Colistimethate and Oramorph sr reports submitted per year:

Colistimethate and Oramorph sr drug interactions.

Common Colistimethate and Oramorph Sr drug interactions by gender *:

female:

  1. Anaphylactoid reaction
  2. Chest discomfort
  3. Infusion site swelling
  4. Irritable bowel syndrome
  5. Lower respiratory tract infection
  6. Multi-organ failure
  7. Neutropenic sepsis
  8. Platelet count decreased
  9. Poor venous access
  10. Productive cough

male:

n/a

Common Colistimethate and Oramorph Sr drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Anaphylactoid reaction
  2. Haemorrhage subcutaneous
  3. Multi-organ failure
  4. Neutropenic sepsis
  5. Platelet count decreased
  6. Respiratory failure
  7. Skin discolouration
  8. Tachycardia

50-59:

n/a

60+:

  1. Chest discomfort
  2. Diarrhoea
  3. Lower respiratory tract infection
  4. Poor venous access
  5. Productive cough
  6. Tracheal disorder
  7. Wheezing
  8. Wound
  9. Dysphonia
  10. Dyspnoea

* Approximation only. Some reports may have incomplete information.

Do you take Colistimethate and Oramorph sr?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Colistimethate and Oramorph sr:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Oramorph sr side effects:

Browse all side effects of Oramorph sr:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Colistimethate interactions:

Browse all interactions between Colistimethate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Oramorph sr interactions:

Browse all interactions between Oramorph sr and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on colistimethate sodium and morphine sulfate (the active ingredients of Colistimethate and Oramorph sr, respectively), and Colistimethate and Oramorph sr (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Colistimethate and Oramorph sr.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.